TAP Biosystems Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:TAP Biosystems Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013325
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a medical laboratory that provides laboratory and pharmaceutical equipment. The laboratory offers products such as single-use mini bioreactor systems and automated cell culture systems. It also provides labware, consumables and accessories. TAP offers services including installation, onsite repair services, preventative maintenance, operator and maintenance training, system and software upgrades, lab relocations and decommissioning, protocol development, and validation and GMP compliance. The laboratory’s products are used for drug discovery, biologics production, bioprocess development, regenerative medicine and tissue engineering. It partners with distribution companies. The laboratory operates in Royston, the UK; and Wilmington, the US. TAP is headquartered in Royston, the UK.

TAP Biosystems Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
TAP Biosystems Ltd, Medical Devices Deals, 2011 to YTD 2017 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
Licensing Agreements 16
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Acquisition 17
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd – Key Competitors 19
TAP Biosystems Ltd – Key Employees 20
TAP Biosystems Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TAP Biosystems Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
TAP Biosystems Ltd, Medical Devices Deals, 2011 to YTD 2017 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd, Key Competitors 19
TAP Biosystems Ltd, Key Employees 20
TAP Biosystems Ltd, Other Locations 21

★海外企業調査レポート[TAP Biosystems Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Maruzen Petrochemical Co Ltd:企業の戦略的SWOT分析
    Maruzen Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Acarix AS:医療機器:M&Aディール及び事業提携情報
    Summary Acarix A/S (Acarix) is a medical device company that provides design and development of non-invasive cardiac screening products. The company provides non-invasive screening device, CADScor system used to record, process and display heart signals as a patient specific score as the CAD-score o …
  • Falcon Oil & Gas Ltd (FO):石油・ガス:M&Aディール及び事業提携情報
    Summary Falcon Oil & Gas Ltd (Falcon), formerly Sanfred Resources Ltd., is a global energy company. It carries out acquisition, exploration and development of large acreage positions of conventional and unconventional oil and gas resources. The company holds interests three major exploration project …
  • JFE Holdings Inc (5411):企業の財務・戦略的SWOT分析
    JFE Holdings Inc (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • AbCheck sro:製薬・医療:M&Aディール及び事業提携情報
    Summary AbCheck Sro (AbCheck), a subsidiary of Affimed NV is a healthcare technology company offers discovery and optimization of high-quality human antibodies. The company offers technology platforms such as Absieve, and AbAccel. Its Absieve is an antibody discovery technology that offers proprieta …
  • Quadrise Fuels International Plc (QFI):石油・ガス:M&Aディール及び事業提携情報
    Summary Quadrise Fuels International Plc (QFI), previously Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multi phase Superfine Atomized Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation …
  • EBN B.V.:石油・ガス:M&Aディール及び事業提携情報
    Summary EBN BV (EBN) is an independent oil and natural gas company that carries out exploration, production, storage and trading of oil and natural gas. The company participates in nearly all the exploration and production activities in the Netherlands through a public-private partnership model. It …
  • Flex Ltd (FLEX)-医療機器分野:企業M&A・提携分析
    Summary Flex Ltd (Flex), formerly Flextronics International Ltd, is a provider of technology solutions. It designs, manufactures and provides supply chain services to original equipment manufacturers. The company’s major solutions include disposables, drug delivery, diagnostics devices, automotive e …
  • Bank of Cyprus Public Company Ltd:企業のM&A・事業提携・投資動向
    Bank of Cyprus Public Company Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Cyprus Public Company Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • AzurRx BioPharma Inc (AZRX):企業の財務・戦略的SWOT分析
    AzurRx BioPharma Inc (AZRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Selvita SA (SLV):企業の財務・戦略的SWOT分析
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • Sempra Energy (SRE):石油・ガス:M&Aディール及び事業提携情報
    Summary Sempra Energy (Sempra) is an energy-services holding company. Through its subsidiaries, the company invests in, develops, and operates energy infrastructure. It carries out utility operations, development of energy infrastructure and related services in countries including the US, Mexico, Ar …
  • Consolidated Edison Solutions Inc:企業の戦略的SWOT分析
    Consolidated Edison Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Sanofi Genzyme:企業の戦略・SWOT・財務情報
    Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report Summary Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • International Consolidated Airlines Group, S.A.:企業の戦略・SWOT・財務分析
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Kangwon Land Inc.
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Westar Energy Inc:企業の発電所・SWOT分析2018
    Westar Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Copperbelt Energy Corporation Plc (CEC):電力:M&Aディール及び事業提携情報
    Summary Copperbelt Energy Corporation PLC (CEC) is an electric utility that generates, transmits, distributes and sells energy. The company generates electricity from hydro, solar, gas and thermal sources; transmits electricity through a network of transmission lines and high voltage substations and …
  • Petroleos de Venezuela SA-エネルギー分野:企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆